RFHIC and MaxLinear Achieve Breakthrough Linearization Performance for Ultra-Wideband 5G New Radio
MaxLinear transceivers and linearization technology combine with RFHIC’s power amplifiers to exceed 3GPP requirements for…
5 years ago
RFHIC and MaxLinear Achieve Breakthrough Linearization Performance for Ultra-Wideband 5G New Radio
MaxLinear transceivers and linearization technology combine with RFHIC’s power amplifiers to exceed 3GPP requirements for…
5 years ago
RFHIC and MaxLinear Achieve Breakthrough Linearization Performance for Ultra-Wideband 5G New Radio
MaxLinear transceivers and linearization technology combine with RFHIC’s power amplifiers to exceed 3GPP requirements for…
5 years ago
Mylab and US-based Hemex Health Announce Technology Partnership for Point-of-Care Diagnostics for COVID-19 and Other Diseases
PUNE, India & PORTLAND, Ore.--(BUSINESS WIRE)--Mylab Discovery Solutions, India’s leading biotechnology company, has joined forces…
5 years ago
Peninsula Health Forges New Model for Healthcare Delivery with Citrix® and Logicalis
Leading Australian healthcare provider transitions staff to working from home, rolls out Telehealth services to…
5 years ago
Peninsula Health Forges New Model for Healthcare Delivery with Citrix® and Logicalis
Leading Australian healthcare provider transitions staff to working from home, rolls out Telehealth services to…
5 years ago
INNIO Joins United Nations Global Compact Further Underscoring Commitment to Sustainability
INNIO joins more than 9,500 companies and 3,000 non-business signatories to support UN goals and…
5 years ago
INNIO Joins United Nations Global Compact Further Underscoring Commitment to Sustainability
INNIO joins more than 9,500 companies and 3,000 non-business signatories to support UN goals and…
5 years ago
PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab
Enrollment in the REVERSE-IT global Phase 3 trial from clinical sites in China expected to…
5 years ago
PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab
Enrollment in the REVERSE-IT global Phase 3 trial from clinical sites in China expected to…
5 years ago